Comparison of the efficacy and safety of drug therapies for macular edema secondary to central retinal vein occlusion. [electronic resource]
Producer: 20191122Description: e022700 p. digitalISSN:- 2044-6055
- Humans
- Adrenal Cortex Hormones -- adverse effects
- Aptamers, Nucleotide -- adverse effects
- Dexamethasone -- adverse effects
- Intraocular Pressure -- drug effects
- Intravitreal Injections
- Macular Edema -- drug therapy
- Randomized Controlled Trials as Topic
- Ranibizumab -- adverse effects
- Receptors, Vascular Endothelial Growth Factor -- therapeutic use
- Recombinant Fusion Proteins -- adverse effects
- Retinal Vein Occlusion -- complications
- Risk Assessment
- Treatment Outcome
- Triamcinolone -- adverse effects
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Network Meta-Analysis
No physical items for this record
Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.